160 related articles for article (PubMed ID: 11950639)
61. 3D TOF MR angiography to depict pituitary bright spot and to detect posterior pituitary lobe cyst: Original description at 3T MR imaging.
Meyrignac O; Idir IS; Cognard C; Bonneville JF; Bonneville F
J Neuroradiol; 2015 Dec; 42(6):321-5. PubMed ID: 26452609
[TBL] [Abstract][Full Text] [Related]
62. MR imaging of cavernous sinus involvement by pituitary adenomas.
Scotti G; Yu CY; Dillon WP; Norman D; Colombo N; Newton TH; De Groot J; Wilson CB
AJR Am J Roentgenol; 1988 Oct; 151(4):799-806. PubMed ID: 3262283
[TBL] [Abstract][Full Text] [Related]
63. Preoperative depiction of cavernous sinus invasion by pituitary macroadenoma using three-dimensional anisotropy contrast periodically rotated overlapping parallel lines with enhanced reconstruction imaging on a 3-tesla system.
Yoneoka Y; Watanabe N; Matsuzawa H; Tsumanuma I; Ueki S; Nakada T; Fujii Y
J Neurosurg; 2008 Jan; 108(1):37-41. PubMed ID: 18173308
[TBL] [Abstract][Full Text] [Related]
64. Transsphenoidal pituitary macroadenomas resection guided by PoleStar N20 low-field intraoperative magnetic resonance imaging: comparison with early postoperative high-field magnetic resonance imaging.
Wu JS; Shou XF; Yao CJ; Wang YF; Zhuang DX; Mao Y; Li SQ; Zhou LF
Neurosurgery; 2009 Jul; 65(1):63-70; discussion 70-1. PubMed ID: 19574826
[TBL] [Abstract][Full Text] [Related]
65. Poor correlation of serum alpha-subunit concentration and magnetic resonance imaging following pituitary surgery in patients with nonfunctional pituitary macroadenomas.
Pineyro MM; Makdissi A; Faiman C; Prayson RA; Reddy SK; Mayberg MC; Weil RJ; Hamrahian AH
Endocr Pract; 2008; 14(4):452-7. PubMed ID: 18558599
[TBL] [Abstract][Full Text] [Related]
66. [Imaging of tumors of the pituitary gland].
Trattnig S; Ba-Ssalamah A; Pinker K; Nöbauer-Huhmann I; Wolfsberger S; Knosp E
Wien Klin Wochenschr; 2003; 115 Suppl 2():23-7. PubMed ID: 15518142
[TBL] [Abstract][Full Text] [Related]
67. Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging.
Sakamoto Y; Takahashi M; Korogi Y; Bussaka H; Ushio Y
Radiology; 1991 Feb; 178(2):441-5. PubMed ID: 1987606
[TBL] [Abstract][Full Text] [Related]
68. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
69. MR imaging of macroadenomas.
Mohammad-Zadeh L
Radiol Technol; 1995; 67(1):29-36; quiz 37-8. PubMed ID: 7491407
[TBL] [Abstract][Full Text] [Related]
70. Endoscopic extracapsular dissection for resection of pituitary macroadenomas: technical note.
Chamoun R; Takashima M; Yoshor D
J Neurol Surg A Cent Eur Neurosurg; 2014 Jan; 75(1):48-52. PubMed ID: 23034885
[TBL] [Abstract][Full Text] [Related]
71. Early versus late Gamma Knife radiosurgery following transsphenoidal resection for nonfunctioning pituitary macroadenomas: a matched cohort study.
Pomeraniec IJ; Dallapiazza RF; Xu Z; Jane JA; Sheehan JP
J Neurosurg; 2016 Jul; 125(1):202-12. PubMed ID: 26517773
[TBL] [Abstract][Full Text] [Related]
72. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
73. Application of Reduced-FOV Diffusion-Weighted Imaging in Evaluation of Normal Pituitary Glands and Pituitary Macroadenomas.
Wang M; Liu H; Wei X; Liu C; Liang T; Zhang X; Jin C; Li X; Sun Q; Jiang H; Yang J
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1499-1504. PubMed ID: 30026383
[TBL] [Abstract][Full Text] [Related]
74. Volume of pituitary macroadenomas: assessment by MRI.
Lundin P; Pedersen F
J Comput Assist Tomogr; 1992; 16(4):519-28. PubMed ID: 1629407
[TBL] [Abstract][Full Text] [Related]
75. Intraoperative magnetic resonance imaging in pituitary macroadenoma surgery: an assessment of visual outcome.
Jones J; Ruge J
Neurosurg Focus; 2007; 23(5):E12. PubMed ID: 18004960
[TBL] [Abstract][Full Text] [Related]
76. Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery.
Bohinski RJ; Warnick RE; Gaskill-Shipley MF; Zuccarello M; van Loveren HR; Kormos DW; Tew JM
Neurosurgery; 2001 Nov; 49(5):1133-43; discussion 1143-4. PubMed ID: 11846908
[TBL] [Abstract][Full Text] [Related]
77. Thyroid-stimulating hormone pituitary adenomas.
Clarke MJ; Erickson D; Castro MR; Atkinson JL
J Neurosurg; 2008 Jul; 109(1):17-22. PubMed ID: 18590428
[TBL] [Abstract][Full Text] [Related]
78. Comparison of magnetic resonance imaging and computed tomography in the preoperative evaluation of pituitary adenomas.
Nichols DA; Laws ER; Houser OW; Abboud CF
Neurosurgery; 1988 Feb; 22(2):380-5. PubMed ID: 2832783
[TBL] [Abstract][Full Text] [Related]
79. Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea.
Chang RJ; Keye WR; Young JR; Wilson CB; Jaffe RB
Am J Obstet Gynecol; 1977 Jun; 128(4):356-63. PubMed ID: 559413
[TBL] [Abstract][Full Text] [Related]
80. Predictive role of dynamic contrast enhanced T1-weighted MR sequences in pre-surgical evaluation of macroadenomas consistency.
Romano A; Coppola V; Lombardi M; Lavorato L; Di Stefano D; Caroli E; Rossi Espagnet MC; Tavanti F; Minniti G; Trillò G; Bozzao A
Pituitary; 2017 Apr; 20(2):201-209. PubMed ID: 27730456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]